Figure 3
Estimated percentage density (and 95% confidence intervals) at baseline and follow up by treatment group (77 women in the isoflavone group and 85 in the placebo; P = 0.82).
Figure 3 | Breast Cancer Research
Estimated percentage density (and 95% confidence intervals) at baseline and follow up by treatment group (77 women in the isoflavone group and 85 in the placebo; P = 0.82).